Live
- Study Reveals Teabags Release Billions of Microplastics and Nanoplastics, Entering Your Body
- Kumbh Mela 2025: Essential Guide to Comfortable and Respectful Attire for Maha Kumbh
- Hyderabad Real Estate Faces Setback: Property Sales Drop 7% Year-on-Year in 2024
- Gnani’s Gen AI Solutions Revolutionising BFSI
- Trump's WHO threat sparks debate on the efficiency of global health governance
- ICC Champions Trophy 2025 Schedule: India vs Pakistan Match Set for February 23 in Dubai
- Champions Trophy 2025: Full Schedule, Match Dates, Venues, Timings, and Updates
- FRAI Urges Government to Provide Technology Platform for Kirana Stores to Stay Competitive
- Not just Gen Z, millennials too: Redditors discuss the wave of pet parenthood embraced by young Indians
- Innovation can expedite the journey to a Smoke-Free future- in focus at Technovation Abu Dhabi
Natco Pharma shares drop 3%
Shares of Natco Pharma on Wednesday dropped over 3 per cent after the company reported 35 per cent decline in consolidated net profit for the quarter ended September 30, 2019.
New Delhi: Shares of Natco Pharma on Wednesday dropped over 3 per cent after the company reported 35 per cent decline in consolidated net profit for the quarter ended September 30, 2019.
The scrip fell 3.39 per cent to close at Rs 560.80 on the BSE. During the day, it tumbled 6.71 per cent to Rs 541.50. On the NSE, it declined 3.20 per cent to close at Rs 560.05.
Natco Pharma on Tuesday reported 35 per cent decline in consolidated net profit at Rs 117.7 crore for the quarter ended September 30, 2019.
The Hyderabad-based company had posted a profit of Rs 181.1 crore in the year-ago period. Total income stood at Rs 518.9 crore for the quarter under review as against Rs 583.5 crore in the year-ago period, a decline of 11 per cent, Natco Pharma said in a BSE filing.
